Abstract
Stenting treatments for the management of disease in the heart, arterial and venous systems, biliary ducts, urethras, ureters, oesophageal tract and prostate have made enormous technical advances since their introduction into clinical use. The progression from metallic to polymer based bio-absorbable stents, coupled with the advances in additive manufacturing techniques, present a unique opportunity to completely re-envision the design, manufacture, and supply chain of stents. This paper looks at current stenting trends and proposes a future where the stent supply chain is condensed from ~150 days to ~20 min. The Cardiologist therefore has the opportunity to become a designer, manufacturer and user with patients receiving custom stents specific to their unique pathology that will be generated, delivered and deployed in the Cath-lab. The paper will outline this potentially revolutionary development and consider the technical challenges that will need to be overcome in order to achieve these ambitious goals. A high level overview of the generating eluting stents in situ program—GENESIS—is outlined including some early experimental work.
Similar content being viewed by others
References
Abizaid, A., and J. R. Costa. New drug-eluting stents an overview on biodegradable and polymer-free next-generation stent systems. Circulation 3:384–393, 2010.
Aktin, T., and R. G. Özdemir. An integrated approach to the one-dimensional cutting stock problem in coronary stent manufacturing. Eur. J. Oper. Res. 196:737–743, 2009.
Alexy, R. D., and D. S. Levi. Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent. Biomed. Res. Int. 11:2013–2015, 2013.
Bartlett, S. Printing organs on demand. Lancet Respir. Med. 9:684, 2013.
Caves, J. M., and E. L. Chaikof. The evolving impact of microfabrication and nanotechnology on stent design. J. Vasc. Surg. 44:1363–1368, 2006.
Colombo, A., G. Stone, A. Kirtane, and D. Kereiakes. Drug-eluting versus bare-metal stents. In: The Medical Roundtable Cardiovascular Edition. FoxP2 Media LLC, 2015.
Dangas, G. D., B. E. Claessen, A. Caixeta, E. A. Sanidas, G. S. Mintz, and R. Mehran. In-stent restenosis in the drug-eluting stent era. J. Am. Coll. Cardiol. 56:1897–1907, 2010.
Fahy P., F. Malone, E. McCarthy, P. McCarthy, J. Thornton, P. Brennan, A. O’Hare, S. Looby, S. Sultan, and N. Hynes. An in vitro evaluation of emboli trajectories within a three-dimensional physical model of the circle of willis under cerebral blood flow conditions. Ann. Biomed. Eng. 1–14, 2015
Frame, M., and J. S. Huntley. Rapid prototyping in orthopaedic surgery: a users guide. Sci. World J. 2012:7, 2012.
Garcíaa, H. G., I. J. Amat Santosa, J. A. San Román Calvar. Intrastent coronary dissection assessed with optical coherence tomography. Rev. Esp. Cardiol. 65(6):570, 2012.
Garg, S., and P. W. Serruys. Coronary stents: looking forward. J. Am. Coll. Cardiol. 56:S43–S78, 2010.
Gitter, D. M. Innovators and imitators: an analysis of proposed legislation implementing an abbreviated approval pathway for follow-on biologics in the United States. Fla. St. UL Rev. 35:555, 2007.
Harms, J., X. Wang, T. Kim, X. Yang, and A. S. Rathore. Defining process design space for biotech products: case study of Pichia pastoris fermentation. Biotechnol. Prog. 24:655–662, 2008.
Hendriks, J. G. E., J. R. van Horn, H. C. van der Mei, and H. J. Busscher. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. Biomaterials 25:545–556, 2004.
Hermawan, H., D. Dubé, and D. Mantovani. Developments in metallic biodegradable stents. Acta Biomater. 6:1693–1697, 2010.
Htay, T., and M. W. Liu. Drug-eluting stent: a review and update. Vasc. Health Risk Manag. 1:263, 2005.
Kahn, J. K., and G. O. Hartzler. Frequency and causes of failure with contemporary balloon coronary angioplasty and implications for new technologies. Am. J. Cardiol. 66:858–860, 1990.
Khan, W., S. Farah, and A. J. Domb. Drug eluting stents: developments and current status. J. Control. Release 161:703–712, 2012.
Kishore, L., and P. Gupta. Vascular imaging: past, present & future. Vascular 26:65, 2013.
Krishnan, S., A. Dawood, R. Richards, J. Henckel, and A. Hart. A review of rapid prototyped surgical guides for patient-specific total knee replacement. J. Bone Joint Surg. Br. 94:1457–1461, 2012.
Lee, S.-Y., and M.-K. Hong. Stent evaluation with optical coherence tomography. Yonsei Med. J. 54:1075–1083, 2013.
Leu, Y. Y., and W. S. Chow. Kinetics of water absorption and thermal properties of poly (lactic acid)/organomontmorillonite/poly (ethylene glycol) nanocomposites. J. Vinyl Addit. Technol. 17:40–47, 2011.
Mani, G., M. D. Feldman, D. Patel, and C. M. Agrawal. Coronary stents: a materials perspective. Biomaterials 28:1689–1710, 2007.
Martinez, A. W., and E. L. Chaikof. Microfabrication and nanotechnology in stent design. Wiley Interdiscip. Rev. 3:256–268, 2011.
McGinty, S., T. T. Vo, M. Meere, S. McKee, and C. McCormick. Some design considerations for polymer-free drug-eluting stents: a mathematical approach. Acta Biomater. 18:213–225, 2015.
Mikkonen, J., I. Uurto, T. Isotalo, A. Kotsar, T. Tammela, M. Talja, J.-P. Salenius, P. Törmälä, and M. Kellomäki. Drug-eluting bioabsorbable stents–An in vitro study. Acta Biomater. 5:2894–2900, 2009.
Moore, S. S., and J. Villaumie. A transferable non-destructive method for the quantification of coronary stent coating components using Raman spectroscopy. J. Raman Spectrosc. 46:353–360, 2015.
Morris, L., F. Stefanov, and T. McGloughlin. Stent graft performance in the treatment of abdominal aortic aneurysms: the influence of compliance and geometry. J. Biomech. 46:383–395, 2013.
Nalladaru, Z. Bioabsorbable coronary stents: the new kid on the block. Arab Health Magazine. pp. 16–18, 2012.
Nguyen, T. D., E. Su, F. Lazarow, F. C. Wheatley, A. Chin-Loy, A. Wang, D. Protsenko, G. S. Ahuja, Z. Chen, and B. J. Wong. Constructing 3D models of the pediatric upper airway from long range optical coherence tomography images. In: Proc. SPIE 8926, Photonic Therapeutics and Diagnostics X, 89262L (March 3, 2014). doi:10.1117/12.2052971
Ormiston, J. A., and P. W. Serruys. Bioabsorbable coronary stents. Circulation 2:255–260, 2009.
Ozbolat, I. T., and Y. Yu. Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans. Biomed. Eng. 60:691–699, 2013.
Poncin, P., and J. Proft. Stent tubing: understanding the desired attributes. In: Proceedings of Materials & Processes for Medical Devices Conference, Anaheim, CA, 8–10 Sept., 2003.
Qi, P., Y. Yang, F. M. Maitz, and N. Huang. Current status of research and application in vascular stents. Chin. Sci. Bull. 58:4362–4370, 2013.
Raval, A., J. Parikh, and C. Engineer. Mechanism of controlled release kinetics from medical devices. Braz. J. Chem. Eng. 27:211–225, 2010.
Roguin, A. Stent: the man and word behind the coronary metal prosthesis. Circulation 4:206–209, 2011.
Schubert, C., M. C. van Langeveld, and L. A. Donoso. Innovations in 3D printing: a 3D overview from optics to organs. Br. J. Ophthalmol. 98(2):159–161, 2014. doi:10.1136/bjophthalmol-2013-304446.
Stoeckel, D., C. Bonsignore, and S. Duda. A survey of stent designs. Minim. Invasive Ther. Allied Technol. 11:137–147, 2002.
Stoeckel, D., A. Pelton, and T. Duerig. Self-expanding nitinol stents: material and design considerations. Eur. Radiol. 14:292–301, 2004.
Thom, T., N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z.-J. Zheng, K. Flegal, C. O’donnell, and S. Kittner. Heart disease and stroke statistics—2006 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85–e151, 2006.
Tumbleston, J. R., D. Shirvanyants, N. Ermoshkin, R. Janusziewicz, A. R. Johnson, D. Kelly, K. Chen, R. Pinschmidt, J. P. Rolland, and A. Ermoshkin. Continuous liquid interface production of 3D objects. Science 347:1349–1352, 2015.
Van Belle, E., C. Bauters, E. Hubert, J.-C. Bodart, K. Abolmaali, T. Meurice, E. P. McFadden, J.-M. Lablanche, and M. E. Bertrand. Restenosis rates in diabetic patients A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96:1454–1460, 1997.
Ventola, C. L. Medical applications for 3D printing: current and projected uses. Pharm. Ther. 39:704, 2014.
Wadhwa, H. S. Stents: Technologies and Global Markets. Massachusetts: BCC, 2015.
Wang, Y., and X. Zhang. Vascular restoration therapy and bioresorbable vascular scaffold. Regen. Biomater. 1:49–55, 2014.
Wiebe, J., H. M. Nef, and C. W. Hamm. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J. Am. Coll. Cardiol. 64:2541–2551, 2014.
Zopf, D. A., S. J. Hollister, M. E. Nelson, R. G. Ohye, and G. E. Green. Bioresorbable airway splint created with a three-dimensional printer. N. Engl. J. Med. 368:2043–2045, 2013.
Acknowledgments
The authors would like to thank the reviewers and editors whose feedback was invaluable in the development of this paper. They would also like to thank Donal Ryan from 3dprint@ul.i.e. for the support in the initial experiments and Aidan G. O’Sullivan for the use of his stent design in this paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Sean McGinty oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Moore, S.S., O’Sullivan, K.J. & Verdecchia, F. Shrinking the Supply Chain for Implantable Coronary Stent Devices. Ann Biomed Eng 44, 497–507 (2016). https://doi.org/10.1007/s10439-015-1471-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-015-1471-8